Quadruplet Isa-KRd Regimen Improves NGS-MRD Negativity in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma By Ogkologos - April 20, 2026 195 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the EMN24 IsKia study Source RELATED ARTICLESMORE FROM AUTHOR Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in First-Line Treatment of dMMR/MSI-H mCRC Use of YEARS Algorithm, D-dimer Levels, and Performing Risk-Dependent CT Pulmonary Angiography is Safe in Patients with Cancer and Suspected Pulmonary Embolism EMA Recommends Extension of Indications for Ponatinib Associated with a New Pharmaceutical Form and a New Strength MOST POPULAR CAR22 Shows Durable Efficacy After a Single Infusion in Patients with... July 25, 2024 Coffee Shop Owner Learns He Has Terminal Cancer – So Competitor... February 11, 2020 Woman Suffers Severe Eye Pain And Swelling, Finds Out She Has... April 17, 2019 EMA Adopts a Positive Opinion for Biosimilar Denosumab May 28, 2025 Load more HOT NEWS ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the... ESMO Welcomes New Cancer Focused UN Political Declaration on Non-Communicable Diseases Cliff Collapse Kills Woman Celebrating Breast Cancer Victory and 2 of... Longitudinal Molecular Profiling of CTCs Captures New Insights in mRCC
